The Separation of Susceptibility to Psoriasis from Age at Onset  by Melski, John W. & Stern, Robert S.
0022-202X/81/7705-0474$02.00/0 
THE JOURNAL OF INVESTIGA'I"lVE DERMATOLOGY, 77:474-477, 1981 
Copyright © 1981 by The Williams & Wilkins Co. 
Vol. 77, No.6 
Printed in U.S.A. 
The Separation of Susceptibility to Psoriasis from Age at Onset 
JOHN W_ MELSKI, M.D., AND ROBERT S. STERN, M.D. 
From the Photo chemotherapy Follow-up Study' and Laboratory of Computer Medicine, Department of Medicine, Beth Israel Hospital (Dr. 
M elshi), and Departments of Dermatology, Beth Israel Hospital and Jfassachusetts General Hospital (Drs. Melslli and Stern), Harvard 
Medical School; Center for the Analysis of Health Practices (Dr. Stern), Harvard School of Public Health; and Charles A. Dana Research 
Institute and Harvard-Thorndille Laboratory of Beth Israel Hospital, Boston, Massachusetts, U.S.A. 
The prevalence of psoriasis among first-degree rela-
tives of 1209 patients with severe psoriasis was studied 
by means of a questionnaire survey. Siblings of patients 
with an affected parent were more than 4 times as likely 
to have psoriasis as siblings of patients without an af-
fected parent. Siblings of patients with onset before age 
15 were more than 3 times as likely to have psoriaris as 
siblings of patients with onset after age 30. The increased 
prevalence associated with each factor was independent 
of the other factor. This relation suggests that determi-
nants of susceptibility to psoriasis are separate from 
factors that influence age at onset in those who are 
susceptible. This separation is important because the 
genetics and biochemistry of susceptibility may be less 
complex than for age at onset. Prevalence among off-
spring was less than age-adjusted prevalence among 
siblings with an affected parent which suggests the ma-
jor determinant of susceptibility is not a single dominant 
allele. 
Like diabetes and other chronic diseases, psoriasis aggregates 
within families, has a delayed onset [1-5], and seldom remits 
complet~ly. However, unlike some chronic diseases and genet-
ically determined traits, it rarely influences longevity. There-
fore, as a patient gets older, the prevalence of psoriasis in a 
given group of relatives will increase, since more of them will 
have time to express their disease. Such increased prevalence 
of psoriasis with increasing age was found in the United States 
population by the Health and Nutrition Examination Survey 
of 1971 to 1974 [6]. 
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The prevalence of affected relatives may also be associated 
with the patient's age at onset if age at onset aggregates within 
families. Several investigators have reported that prevalence of 
affected relatives is higher for patients with earlier onset, but 
none has corrected for age [7- 9]. Among patients with a disease 
that has a delayed onset, age may be confounded with the 
effects of age at onset, and vice versa. 
This study examines the associations between age, age at 
onset, and prevalence of psoriasis among the fIrst-degree rela-
tives of patients with severe disease. 
METHODS 
Study PopUlation 
The patient population for this study was originally composed of 
1253 patients with severe psoriasis who were enrolled from 1975 to 1976 
at 15 centers for treatment with 8-methoxypsoralen and longwave 
ultraviolet light (PUVA) . These patients, previously described [10], had 
extensive disease (an average of 33% of surface area involved) of long 
duration (an average of 19 yr) and had used several types of therapy 
for their disease, including methotrexate and hospitalization for the 
Goeckerman regimen. Of the 1,253 patients, 22 were excluded from the 
study because of incomplete information about age or age at onset, and 
22 patients over age 74 were excluded because of sample sizes when 
patients were partitioned according to age at onset. The remaining 
1,209 patients formed our final study population. 
Data Collection 
Information about age, birthdate, the age at which psoriasis began, 
and family history of psoriasis was obtained by means of a questionnaire 
administered in-person by the co-investigators at each center. Criteria 
for the onset of psoriasis were not suggested to the patient. The 
questions regarding first-degree relatives were as follows: 
Does your mother have psoriasis? 
A. yes B. no C. not SUl"e 
Does your father have psoriasis? 
A. yes B. no C. not sure 
How many brothers and sisters do you have? 
How many brothers and sisters are you sure have had psoriasis? 
How many children do you have? 
How many children are you sure have had psoriasis? 
Standardized forms were also used to collect details of physical 
examinations done by dermatologists. All data were entered, stored, 
and analyzed using a computer-based data management system, which 
has previously been described [11). 
Age and Age at Onset Partitions 
Patients were partitioned according to age and age at onset (Fig 1) . 
(Unless otherwise stated, "age" and "age 'at onset" apply to patients 
rather than to relatives.) For each age and age at onset, we determ.ined 
the percent of affected siblings for patients with and without an affected 
parent (fig 2 and 3, respectively) and the percent of affected offspring 
(Fig 4). 
We also determined the effects of introducing a proband bias among 
offspring (Fig 5). There were 75 patients with at least one offspring 
with psoriasis, among 710 patients with more than one offspring. We 
considered one affected offspring as a proband for each of these 75 
families and found the prevalence of psoriasis among the remaining 
offspring. We compared this prevalance with the prevalence among 
siblings of patients who were 15 yr younger and who had an affected 
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FIG 1. Age versus age at onset of patients. 
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FIG 2. Prevalences of psoriasis anlOng siblings of patients with an 
affected parent. 
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FIG 3. Prevalences of psoriasis among siblings of patients without 
an affected parent. 
parent. The small numbers of offspring reported by patients less than 
30 were excluded. 
To facilitate comparisons, percents were represented in the figures 
as proportional squares. No percents based on the family histories of 
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fewer than 6 patients were used, except for the proband study, in which 
no percents based on fewer than 4 patients were used. The percents 
represent estimates of the cumulative prevalence, or risk, of psoriasis 
during the lifetimes of the relatives under consideration. 
Statistical Analysis 
All associations were studied by pairwise comparisons of prevalences 
using Fisher's exact test to compute one-sided probabilities and Mantel-
Haenszel's chi to compute confidence intervals for prelavence ratios 
according to the method of Miettinen [12]. 
RESULTS 
Siblings 
Pairwise comparisons of the 11 prevalences in Fig 2 with the 
corresponding prevalences in Fig 3 showed that psoriasis in a 
parent of a patient was associated with a 4.4-fold median 
increase in the prevalence of affected siblings (range, 2.2 to 6.1; 
the'lower bound of all 95% confidence intervals for these prev-
alence ratios exceeded 1.2). There was no systematic change in 
these ratios with different ages or ages at onset, or with the sex 
of the parent. 
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FIG 4. Prevalences of psoriasis among offspring of patients. 
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FIG 5. Prevalences of psoriasis among offspring of patients after one 
affected offspring has been removed from each family. 
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The prevalence of psoriasis among siblings related to parental 
psoriasis and the patient's age at onset" 
Parental psoriasis Prevalence 
Yes No ratio 
Age at onset [95% CI·] 
0-14 39.7% 8.4% 4.7 
(31/78) (21/249) [3.0-7.5] 
30-74 11.4% 2.9% 4.0 
(19/167) (25/876) [2.3-6.8] 
Prevalence ratio 3.5 3.0 13.9 
[95% CI] [2.2- 5.6] [1.7-5.1] [9.4- 20.6] 
" Only siblings of patients over the age of 30 are represented. 
• Confidence interval. 
Pairwise comparisons of prevalences of affected siblings 
within each column in Figs 2 and 3 showed an increase with 
earlier onset, regardless of parental history (P < .05 for com-
parisons of the extreme age at onset groups within the oldest 3 
age categories in both Fig 2 and 3). The relation of parental 
history and age at onset to the prevalence of affected siblings 
can be seen in the Table. Parental psoriasis was associated with 
a 4.0-fold increase for patients with onset after age 30 and a 4.7-
fold increase for patients with onset before age 15. Onset before 
age 15 was associated with a 3.0-fold increase for patients with 
no affected parent and a 3.5-fold increase for patients with an 
affected parent. Thus, the increases in prevalence were inde-
pendent of the presence of the other factor and resulted in a 
13.9-fold increase when both factors were present. The 45 to 
59-year age group demonstrates this marked increase: the prev-
alence of affected siblings was over 40% (15/32) for patients 
with onset before age 15 and an affected parent (Fig 2), com-
pared to less than 3% (3/103) for patients with onset after age 
45 and no affected parent (Fig 3) . 
Pairwise comparisons of prevalences of affected siblings 
within each row of Fig 2 and 3 showed a trend toward an 
increase with older age (P < 0.5 for comparisons of the extreme 
age groups within the earliest 2 onset categories in Fig 2). 
Offspring 
Pairwise comparisons of prevalences of affected offspring in 
Fig 4 showed an increase with earlier onset (P < .03 for 
comparisons of the extreme age at onset groups wjthin the 
oldest 2 age categories) and an increase with older age (P < .05 
for comparisons of the extreme age groups within all onset 
categories). The prevalence among offspring was lower than 
among siblings with an affected parent for all corresponding 
onset groups, even when we allowed for a 30-yr intergenera-
tional age difference (P < .03 for 2 of 5 comparisons of columns 
2 and 3 of Fig 2 with column£ 4 and 5 of Fig 4). 
Determination of the prevalences of affected offspring for 
patients with and without an affected parent and for patients 
with and without an affected sibling resulted in s0.\TIe zero 
prevalence estimates; therefore, patients with ages 30 to 59 and 
ages at onset 15 to 44 were combined, offspring in this group 
(which included 60 percent of all offspring) were compared. 
Psoriasis in a parent of a patient was associated with a l.6-fold 
increase in prevalence of affected offspring (95 percent confi-
dence interval, 0.8 to 3.1). Psoriasis in a sibling of a patient was 
associated with a l.3:fold increase (95 percent confidence inter-
val, 0.7 to 2.6); and psoriasis in both a parent and a sibling was 
associated with a 2.4-fold increase' (95% confidence interval, l.0 
to 5.8). 
Proband Study of Offspring 
When we compared the middle 3 columns of Fig 2 with Fig 
5 (to allow for a 15-yr intergenerational age difference), preva-
lences for offspring in the proband study were comparable to 
those for siblings of patients with an affected parent, except for 
the 15 to 29-yr onset row (P > .1 for 6 comparisons, and P = 
.01 for 1 comparison) . 
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Parents 
Of their 2,484 parents, patients reported 11.6% with psoriasis 
and were unsure of 6.9%. "Yes" and "no" responses for whether 
a parent had psoriasis were independent (P > 0.2) .and thus 
provided no evidence for assortative mating or associative re-
porting biases. However, when a patient was unsure about one 
parent, he was more likely to be unsure about the other than 
would be expected by chance (P < .0001). A similar association 
of uncertainty was found in reporting psoriasis in grandparents; 
37% of patients were unsure of all grandparents, and only 10% 
reported that at least one grandparent had psoriasis. 
To study the relation of a patient's age and age at onset with 
the prevalence of affected parents, only data from patients who 
were cerain about both parents were used. The overall preva-
lence of 12.3% (274/2222) varied little with age or age at onset; 
however, in the 60 to 74-yr age group, 27% of parents of patients 
in the earliest onset group (6/22) had psoriasis, compared to 5 
(5/92) and 7% (1O/13G) in the next to latest and latest onset 
groups, respectively (P < .01 for comparison of the extreme age 
at onset groups) . A downward trend in prevalence with older 
age was noted for the 2 latest onset groups (P < .02 for 
comparison of the extreme age groups in the 30 to 44 yr onset 
category). 
Examination of the relation of a patient's age and age at 
onset with uncertainty about both parents (N = 40) showed 
that uncertainty increased with the patient's age (P < .05 for 
comparisons of the extreme age groups within in the middle 2 
onset catogories), but no difference existed between onset 
groups within any given age group (P 0.15 for the most deviant 
pair) . Analysis of uncertainty about grandparents also revealed 
increased uncertainty with increasing age of the patient, but no 
relation to age at onset. 
DISCUSSION 
A 40% prevalence of psoriasis among siblings of patients with 
an affected parent and onset before age 15 is higher than any 
prevalence among siblings reported in previous cross-sectional 
surveys. The prevalence observed for this selected group is 
probably not an artifact, since there was a consistent graded 
increase in prevalence with earlier onset for all fU'st-degree 
relatives. Furthermore, our crude prevalence of 9.4% (330/ 3500) 
is comparable to that previously reported for siblings of patients 
with similar ages and ages at onset (7). Previous investigations 
did not account for the possibility that parental psoriasis and 
earlier onset could have independent associations with in-
creased prevalence. 
Since parental psoriasis and earlier onset are each associated 
with an increased prevalence that is not changed in'the presence 
of the other, we hypothesize that these increases are mediated 
by different mechanisms. Parental psoriasis may be a marker 
for parental genotypes that carry a higher risk of absolute 
susceptibility to psoriasis among siblings of a patient, whereas 
earlier onset may be a marker for other environmental or 
genetic factors, such as HL-A types [13-15], that influence the 
expression of psoriasis in those who are susceptible. Factors 
that influence age at onset may be less important in determining 
the history of parental psoriasis, since parents have more time 
to express psoriasis. We would predict that biochemical or 
physiologic correlates of susceptibility are more likely to be 
found among siblings of patients with an affected parent, and 
that siblings with these correlates are more likely to either have 
or develop psoriasis in the near future if the patient had an 
early onset. 
Twin studies provide evidence that psoriasis is hereditary 
[16,17]. However, the mode of inheritance remains speculative, 
since it is difficult to distinguish between such diverse mecha-
nisms as multifactorial inheritance and 2 alleles at a single locus 
with only empiric data [18]. If a single dominant allele were the 
major determinant of psoriasis, the age-adjusted prevalence 
among offspring in ow' study should have been the same as 
Dec. 1981 
among siblings with an affected parent. However, prevalence 
among offspring was consistently lower. The proband study of 
offspring validates our data, since the age-adjusted prevalence , 
among siblings of an affected offspring was similar to that 
among siblings of a patient with an affected parent. Because 
this prevalence was higher than the overall prevalence among 
offspring, it follows that the conditional risk to offspring in a 
given family must decrease relative to overall risk the longer all 
offspring in that family remain free of disease. 
It is possible that the mode of inheritance may differ among 
families. Selected pedigrees have been used to ru'gue for a 
dominant inheritance [19,20]. However, for a disease as com-
mon as psoriasis, such pedigrees may be due to chance and 
another mode of inheritance rather than a dominant allele. 
Among 862 patients with at least one offspring, 21 [2.4%] 
reported psoriasis in both an offspring and a parent. If the 
history of psoriasis in a parent or a sibling served as a marker 
for families with a dominant allele, such a history should be 
associated with increased prevalence in the patient 's offspring. 
We found some association, with prevalence ratios of 1.6 for 
parental psoriasis and 1.3 for sibling psoriasis. However, the 
small magnitude of these increases suggests that they could be 
due to an associative reporting bias. Therefore, we do not 
believe that a dominant allele is the major determinant of 
psoriasis in most families, but we cannot exclude this mode of 
inheritance in some families. Furthermore, the data do not 
exclude other genetic mechanisms, such as autosomal recessive 
trait with high gene frequency and an age at onset determined 
by environmental or genetic factors, or both (for example, 
infections and HL-A types). Without a better understanding of 
the etiologies of psoriasis, genetic counseling and prognosis for 
unaffected relatives must be based on empiric risk [21]. 
Some of the increased prevalence associated with earlier 
onset may be artifact . If a patient was young when his disease 
began, he might overreport psoriasis in his family. Conversely, 
if psoriasis was present in a family before the patient developed 
his disease, he might report an earlier onset. However, there 
was no evidence for a large and consistent associative reporting 
bias. Furthermore, there was no association between age at 
onset and uncertainty about parental psoriasis. We conclude 
that age at onset does aggregate within families. 
The prevalence of affected parents did not show the expected 
increase with age. However, there was an increase of uncer-
tainty about parents with age that might be related to underre- ' 
porting. Moreover, the questions concerning parents referred to 
point prevalence, whereas those concerning siblings and off-
spring referred to cumulative prevalence. Point prevalence may 
be less than cumulative because of spontaneous remissions. 
Twenty seven percent of our patients reported at least one 
spontaneous remission. The completeness and duration of these 
remissions are unknown, although complete remissions of long 
duration are unusual. The associations between age, age at 
onset, and the incidence of spontaneous remissions are also 
unknown. 
A questionnaire survey may underestimate the prevalence of 
psoriasis in relatives and overestimate the age at onset [8]. 
Patient selection itself may be influenced by age at onset and 
family history. The family dispersion that increases with age 
may selectively decrease reliability of family histories in older 
patients. Perhaps the reliability of family history and age at 
onset could be improved in future studies by use of graded 
scales for severity (for example, psoriasis severe enough to be 
first noticed, compared to psoriasis severe enough to be fIrst 
treated), and certainty. 
The severity of psoriasis among our patients may limit the 
applicability of our fmdings. However, the crude prevalences 
for psoriasis among parents (12.3%), siblings (9.4%), and off-
spring (4.5%) agree with those previously reported for patients 
with less extensive disease but similru' ages and ages at onset 
[7]. Furthermore, there was no systematic association of age or 
age at onset with severity, as measul"ed by percent of skin 
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involved, extent of involvement of scalp, palms, soles, nails, or 
intertriginous areas, thickness of plaques, type and extent of 
scale or erythema, previous hospitalizations for psoriasis, ex-
posure to methotrexate, or unfavorable response to photochem-
otherapy. 
We did not collect information about the ages of the relatives 
of patients or even their survival status. Therefore, we cannot 
check for certain types of bias. For example, decreased longevity 
among parents would contribute to decreased reporting of 
psoriasis among parents, and longevity of parents might be 
inversely related to age at onset among pat~ents. 
The conclusions in this paper are based on exploratory data 
analysis. Therefore, our results need to be confIrmed, and 
existing data could be used for this purpose. The independent 
influence of parental psoriasis and earlier onset on the preva-
lence of psoriasis among siblings suggests that determinants of 
susceptibility to psoriasis are separate from factors that influ-
ence age at onset in those who are susceptible. If confIrmed, 
this concept should renew the hope of fmding a specific etiology 
for susceptibility to psoriasis within families. 
We are indebted to Ms. Sally Zierler and Drs. Howard Bleich, John 
Parrish, and Thomas Fitzpatrick for their advice and to Mary J ean 
Moore for editorial assistance. 
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